Precigen (PGEN) Net Cash Flow (2012 - 2026)
Precigen (PGEN) reported Net Cash Flow of -$22.8 million for Q1 2026, up 3.03% year-over-year from -$22.1 million in Q1 2025, and down 243.16% quarter-over-quarter from $15.9 million in Q4 2025.
Precigen (PGEN) Net Cash Flow (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Net Cash Flow data on file, last reported at -$22.8 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$22.8 million, up 3.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 111.88% YoY), and the FY2025 annual result was $682000.0, down 96.86% from the prior year.
- Net Cash Flow declined to -$22.8 million in Q1 2026 per PGEN's latest filing, from $15.9 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $42.3 million in Q3 2022 and troughed at -$43.3 million in Q4 2022.
- A 5-year average of -$2.0 million and a median of -$2.4 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 709.72% in 2022 and fell as far as 3616.83% in 2022.
- A 5-year view of Net Cash Flow shows it stood at -$43.3 million in 2022, then soared by 94.28% to -$2.5 million in 2023, then soared by 293.85% to $4.8 million in 2024, then jumped by 231.5% to $15.9 million in 2025, then tumbled by 243.16% to -$22.8 million in 2026.
- Business Quant data shows PGEN's Net Cash Flow at -$22.8 million in Q1 2026, $15.9 million in Q4 2025, and $552000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 664,983.53 |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | -22.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.75 Mn |
| Mar 31, 2026 | -22.75 Mn |
| Dec 31, 2025 | 15.89 Mn |
| Dec 31, 2025 | 15.89 Mn |
| Sep 30, 2025 | 552,000.00 |
| Sep 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 7.70 Mn |
| Mar 31, 2025 | -23.46 Mn |
| Mar 31, 2025 | -23.46 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 15.05 Mn |
| Sep 30, 2024 | 15.05 Mn |
| Jun 30, 2024 | -8.10 Mn |
| Jun 30, 2024 | -8.10 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Dec 31, 2023 | -2.47 Mn |